T1	Disease	27	52	dementia with Lewy bodies	UMLS:C0752347	Lewy Body Disease
T45	Disease	53	78	Dementia with Lewy bodies	UMLS:C0752347	Lewy Body Disease
T46	Disease	151	159	dementia	UMLS:C0497327	Dementia
T47	Disease	225	250	dementia with Lewy bodies	UMLS:C0752347	Lewy Body Disease
T101	Disease	277	303	neurodegenerative diseases	UMLS:C0524851	Neurodegenerative Disorders
T48	Disease	379	404	dementia with Lewy bodies	UMLS:C0752347	Lewy Body Disease
T102	Disease	410	429	Parkinson’s disease	UMLS:C0030567	Parkinson Disease
T106	Phenotype	487	571	symptoms into cognitive, neuropsychiatric, movement, autonomic, and sleep categories	UMLS:C0525041	Neurobehavioral Manifestations
T107	Phenotype	487	571	symptoms into cognitive, neuropsychiatric, movement, autonomic, and sleep categories	UMLS:C3534763	One or more neuropsychiatric symptoms
T108	Phenotype	487	571	symptoms into cognitive, neuropsychiatric, movement, autonomic, and sleep categories	UMLS:C0426980	Motor symptoms
T109	Phenotype	487	571	symptoms into cognitive, neuropsychiatric, movement, autonomic, and sleep categories	UMLS:C2674101	Autonomic symptoms
T110	Phenotype	487	571	symptoms into cognitive, neuropsychiatric, movement, autonomic, and sleep categories	UMLS:C2232698	sleep symptoms
T103	Drug	898	923	Cholinesterase inhibitors	UMLS:C0008425	Cholinesterase Inhibitors
T104	Phenotype	942	981	cognitive and neuropsychiatric symptoms	UMLS:C0525041	Neurobehavioral Manifestations
T105	Phenotype	942	981	cognitive and neuropsychiatric symptoms	UMLS:C3534763	One or more neuropsychiatric symptoms
T111	Drug	983	995	rivastigmine	DrugBank:DB00989	Rivastigmine
T112	Drug	1108	1131	neuroleptic medications	UMLS:C0040615	Antipsychotic Agents
T113	Drug	1248	1260	Pimavanserin	DrugBank:DB05316	Pimavanserin
T114	Drug	1274	1306	serotonin 5-HT2A inverse agonist	UMLS:C2936524	Serotonin 5-HT2A Receptor Antagonists
T116	Drug	1384	1402	Levodopa/carbidopa	UMLS:C0353697	Carbidopa / Levodopa
T117	Phenotype	1416	1428	parkinsonism	HPO:HP:0001300	Parkinsonism
T118	Phenotype	1479	1518	neuropsychiatric and cognitive symptoms	UMLS:C3534763	One or more neuropsychiatric symptoms
T119	Phenotype	1479	1518	neuropsychiatric and cognitive symptoms	UMLS:C0525041	Neurobehavioral Manifestations
T120	Phenotype	1520	1538	Autonomic symptoms	UMLS:C2674101	Autonomic symptoms
T121	Disease	1577	1592	synucleinopathy	null	null
T122	Phenotype	1594	1606	Constipation	HPO:HP:0002019	Constipation
T123	Phenotype	1608	1624	urinary symptoms	UMLS:C0426359	Urinary symptoms
T124	Phenotype	1629	1649	postural hypotension	HPO:HP:0001278	Orthostatic hypotension
T76	Disease	1683	1725	Rapid eye movement sleep behavior disorder	UMLS:C0751772	REM Sleep Behavior Disorder
T126	Disease	1759	1776	synucleinopathies	null	null
T127	Treatment	1778	1807	Nonpharmacological treatments	null	null
T128	Drug	1809	1818	melatonin	DrugBank:DB01065	Melatonin
T129	Drug	1823	1833	clonazepam	DrugBank:DB01068	Clonazepam
T2	Disease	1853	1884	Dementia with Lewy bodies (DLB)	UMLS:C0752347	Lewy Body Disease
T3	Disease	2091	2094	DLB	UMLS:C0752347	Lewy Body Disease
T49	Disease	2115	2123	dementia	UMLS:C0497327	Dementia
T50	Disease	2208	2216	dementia	UMLS:C0497327	Dementia
T51	Disease	2295	2303	dementia	UMLS:C0497327	Dementia
T52	Disease	2225	2259	Parkinson’s disease dementia (PDD)	UMLS:C0349081	Dementia in Parkinson's disease
T4	Disease	2323	2326	DLB	UMLS:C0752347	Lewy Body Disease
T53	Disease	2331	2334	PDD	UMLS:C0349081	Dementia in Parkinson's disease
T130	Phenotype	2363	2394	accumulation of alpha-synuclein	null	null
T131	Phenotype	2414	2426	parkinsonism	HPO:HP:0001300	Parkinsonism
T132	Phenotype	2447	2464	cognitive decline	HPO:HP:0001268	Mental deterioration
T133	Disease	2483	2486	PDD	UMLS:C0349081	Dementia in Parkinson's disease
T134	Phenotype	2492	2509	Cognitive decline	HPO:HP:0001268	Mental deterioration
T135	Phenotype	2514	2526	parkinsonism	HPO:HP:0001300	Parkinsonism
T136	Phenotype	2681	2698	movement disorder	HPO:HP:0100022	Abnormality of movement
T5	Disease	2770	2773	DLB	UMLS:C0752347	Lewy Body Disease
T137	Disease	2778	2781	PDD	UMLS:C0349081	Dementia in Parkinson's disease
T6	Disease	3195	3198	DLB	UMLS:C0752347	Lewy Body Disease
T138	Disease	3202	3205	PDD	UMLS:C0349081	Dementia in Parkinson's disease
T77	Disease	3253	3277	Parkinson’s disease (PD)	UMLS:C0030567	Parkinson Disease
T7	Disease	3347	3350	DLB	UMLS:C0752347	Lewy Body Disease
T140	Drug	3489	3509	dopamine replacement	null	null
T141	Phenotype	3564	3589	neuropsychiatric symptoms	UMLS:C3534763	One or more neuropsychiatric symptoms
T142	Drug	3591	3614	antipsychotic treatment	UMLS:C0040615	Antipsychotic Agents
T143	Phenotype	3618	3632	hallucinations	HPO:HP:0000738	Hallucinations
T144	Drug	3681	3705	cholinesterase inhibitor	UMLS:C0008425	Cholinesterase Inhibitors
T145	Phenotype	3719	3737	cognitive symptoms	UMLS:C0525041	Neurobehavioral Manifestations
T147	Disease	3753	3794	cardiac and gastrointestinal dysautonomia	UMLS:C3549456	Gastrointestinal dysautonomia
T8	Disease	3835	3838	DLB	UMLS:C0752347	Lewy Body Disease
T148	Phenotype	4374	4389	general malaise	UMLS:C0231218	Malaise
T9	Disease	4510	4513	DLB	UMLS:C0752347	Lewy Body Disease
T151	Phenotype	4640	4719	symptom categories: cognitive, neuropsychiatric, movement, autonomic, and sleep	UMLS:C0525041	Neurobehavioral Manifestations
T154	Phenotype	4640	4719	symptom categories: cognitive, neuropsychiatric, movement, autonomic, and sleep	UMLS:C2674101	Autonomic symptoms
T155	Phenotype	4640	4719	symptom categories: cognitive, neuropsychiatric, movement, autonomic, and sleep	UMLS:C2232698	sleep symptoms
T10	Disease	4741	4744	DLB	UMLS:C0752347	Lewy Body Disease
T156	Disease	4757	4774	cognitive disease	UMLS:C0009241	Cognition Disorders
T157	Phenotype	4812	4833	noncognitive symptoms	null	null
T11	Disease	5207	5210	DLB	UMLS:C0752347	Lewy Body Disease
T158	Disease	5225	5244	Alzheimer’s disease	UMLS:C0002395	Alzheimer's Disease
T160	Phenotype	5278	5333	attention, executive function, and visuospatial ability	UMLS:C1843023	Loss of executive functions
T159	Phenotype	5278	5333	attention, executive function, and visuospatial ability	UMLS:C0238707	Impairment of attention
T161	Phenotype	5278	5333	attention, executive function, and visuospatial ability	HPO:HP:0010794	Impaired visuospatial constructive cognition
T162	Drug	5350	5384	cholinesterase inhibitor treatment	UMLS:C0008425	Cholinesterase Inhibitors
T163	Disease	5570	5573	PDD	UMLS:C0349081	Dementia in Parkinson's disease
T14	Disease	5744	5747	DLB	UMLS:C0752347	Lewy Body Disease
T164	Drug	5621	5655	cholinesterase inhibitor treatment	UMLS:C0008425	Cholinesterase Inhibitors
T165	Disease	5659	5678	Alzheimer’s disease	UMLS:C0002395	Alzheimer's Disease
T12	Disease	5785	5788	DLB	UMLS:C0752347	Lewy Body Disease
T166	Phenotype	5821	5834	neuronal loss	HPO:HP:0002529	Neuronal loss in central nervous system
T167	Disease	5763	5774	Alzheimer’s	UMLS:C0002395	Alzheimer's Disease
T168	Phenotype	5848	5871	cholinergic dysfunction	null	null
T13	Disease	5929	5932	DLB	UMLS:C0752347	Lewy Body Disease
T170	Drug	6007	6041	Cholinesterase inhibitor treatment	UMLS:C0008425	Cholinesterase Inhibitors
T15	Disease	6313	6316	DLB	UMLS:C0752347	Lewy Body Disease
T171	Drug	6284	6309	cholinesterase inhibitors	UMLS:C0008425	Cholinesterase Inhibitors
T172	Disease	6320	6323	PDD	UMLS:C0349081	Dementia in Parkinson's disease
T173	Drug	6329	6341	rivastigmine	DrugBank:DB00989	Rivastigmine
T174	Drug	6450	6462	rivastigmine	DrugBank:DB00989	Rivastigmine
T175	Disease	6479	6482	PDD	UMLS:C0349081	Dementia in Parkinson's disease
T176	Drug	6512	6537	cholinesterase inhibitors	UMLS:C0008425	Cholinesterase Inhibitors
T177	Drug	6542	6551	memantine	DrugBank:DB01043	Memantine
T16	Disease	6655	6658	DLB	UMLS:C0752347	Lewy Body Disease
T178	Drug	6612	6636	cholinesterase inhibitor	UMLS:C0008425	Cholinesterase Inhibitors
T179	Phenotype	6698	6719	autonomic dysfunction	HPO:HP:0002459	Dysautonomia
T181	Phenotype	6790	6801	bradycardia	HPO:HP:0001662	Bradycardia
T182	Disease	6832	6861	Gastrointestinal dysautonomia	UMLS:C3549456	Gastrointestinal dysautonomia
T183	Drug	6921	6945	cholinesterase inhibitor	UMLS:C0008425	Cholinesterase Inhibitors
T184	Phenotype	6962	6968	nausea	HPO:HP:0002018	Nausea
T185	Phenotype	6970	6978	vomiting	HPO:HP:0002013	Vomiting
T186	Phenotype	6980	6988	diarrhea	HPO:HP:0002014	Diarrhea
T187	Phenotype	6990	6998	anorexia	HPO:HP:0002039	Anorexia
T188	Phenotype	7004	7015	weight loss	HPO:HP:0001824	Weight loss
T189	Drug	7070	7122	antagonists of dopamine, acetylcholine, or histamine	UMLS:C0242702	Dopamine Antagonists
T190	Drug	7070	7122	antagonists of dopamine, acetylcholine, or histamine	UMLS:C0242897	Cholinergic Antagonists
T191	Drug	7070	7122	antagonists of dopamine, acetylcholine, or histamine	UMLS:C0019590	Histamine Antagonists
T192	Drug	7135	7161	5HT-3 receptor antagonists	UMLS:C2936526	Serotonin 5-HT3 Receptor Antagonists
T193	Drug	7170	7181	ondansetron	DrugBank:DB00904	Ondansetron
T194	Drug	7185	7196	granisetron	DrugBank:DB00889	Granisetron
T219	Drug	7198	7210	Rivastigmine	DrugBank:DB00989	Rivastigmine
T17	Disease	7283	7286	DLB	UMLS:C0752347	Lewy Body Disease
T195	Drug	7430	7455	cholinesterase inhibitors	UMLS:C0008425	Cholinesterase Inhibitors
T177	Phenotype	7312	7328	disordered sleep	UMLS:C0851578	Sleep Disorders
T178	Phenotype	7373	7385	vivid dreams	UMLS:C0344320	Detailed recall of dream
T196	Drug	7519	7544	cholinesterase inhibitors	UMLS:C0008425	Cholinesterase Inhibitors
T18	Disease	7665	7668	DLB	UMLS:C0752347	Lewy Body Disease
T79	Disease	7672	7675	PDD	UMLS:C0349081	Dementia in Parkinson's disease
T222	Drug	7652	7661	memantine	DrugBank:DB01043	Memantine
T19	Disease	7786	7789	DLB	UMLS:C0752347	Lewy Body Disease
T197	Drug	7840	7874	cholinesterase inhibitor treatment	UMLS:C0008425	Cholinesterase Inhibitors
T206	Disease	7770	7773	PDD	UMLS:C0349081	Dementia in Parkinson's disease
T80	Disease	7979	7981	PD	UMLS:C0030567	Parkinson Disease
T81	Disease	7982	7985	PDD	UMLS:C0349081	Dementia in Parkinson's disease
T223	Drug	7885	7896	Atomexetine	DrugBank:DB00289	Atomoxetine
T224	Drug	7903	7913	rasagiline	DrugBank:DB01367	Rasagiline
T225	Drug	7923	7931	levodopa	DrugBank:DB01235	Levodopa
T20	Disease	8041	8044	DLB	UMLS:C0752347	Lewy Body Disease
T226	Phenotype	8004	8011	Anxiety	HPO:HP:0000739	Anxiety
T227	Phenotype	8016	8026	depression	HPO:HP:0000716	Depression
T54	Disease	8214	8222	dementia	UMLS:C0497327	Dementia
T55	Phenotype	8197	8209	parkinsonism	HPO:HP:0001300	Parkinsonism
T217	Disease	8132	8147	synucleinopathy	null	null
T228	Phenotype	8111	8128	nonmotor symptoms	null	null
T229	Phenotype	8149	8156	anxiety	HPO:HP:0000739	Anxiety
T230	Phenotype	8161	8171	depression	HPO:HP:0000716	Depression
T218	Disease	8353	8368	synucleinopathy	null	null
T231	Phenotype	8538	8550	parkinsonism	HPO:HP:0001300	Parkinsonism
T232	Phenotype	8444	8451	anxiety	HPO:HP:0000739	Anxiety
T233	Phenotype	8456	8466	depression	HPO:HP:0000716	Depression
T21	Disease	8621	8624	DLB	UMLS:C0752347	Lewy Body Disease
T207	Disease	8628	8631	PDD	UMLS:C0349081	Dementia in Parkinson's disease
T234	Phenotype	8610	8617	anxiety	HPO:HP:0000739	Anxiety
T235	Phenotype	8638	8648	Depression	HPO:HP:0000716	Depression
T236	Phenotype	8665	8690	neuropsychiatric symptoms	UMLS:C3534763	One or more neuropsychiatric symptoms
T237	Drug	8741	8753	rivastigmine	DrugBank:DB00989	Rivastigmine
T238	Drug	8763	8773	olanzapine	DrugBank:DB00334	Olanzapine
T239	Drug	8816	8826	citalopram	DrugBank:DB00215	Citalopram
T240	Drug	8831	8842	risperidone	DrugBank:DB00734	Risperidone
T22	Disease	8992	8995	DLB	UMLS:C0752347	Lewy Body Disease
T241	Phenotype	8978	8988	depression	HPO:HP:0000716	Depression
T242	Drug	8997	9006	Serotonin	UMLS:C0036751	Serotonin
T243	Drug	9011	9054	serotonin/norepinephrine reuptake inhibitor	UMLS:C1579361	Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
T244	Drug	9055	9070	antidepressants	UMLS:C0003289	Antidepressive Agents
T245	Phenotype	9121	9131	depression	HPO:HP:0000716	Depression
T23	Disease	9234	9237	DLB	UMLS:C0752347	Lewy Body Disease
T246	Treatment	9146	9173	Electroconvulsive treatment	UMLS:C0013806	Electroconvulsive Therapy
T247	Treatment	9178	9211	transcranial magnetic stimulation	UMLS:C0436548	Transcranial magnetic stimulation
T24	Disease	9286	9289	DLB	UMLS:C0752347	Lewy Body Disease
T248	Phenotype	9248	9262	Hallucinations	HPO:HP:0000738	Hallucinations
T249	Disease	9404	9423	Alzheimer’s disease	UMLS:C0002395	Alzheimer's Disease
T250	Disease	9476	9495	Alzheimer’s disease	UMLS:C0002395	Alzheimer's Disease
T251	Phenotype	9497	9511	hallucinations	HPO:HP:0000738	Hallucinations
T25	Disease	9660	9663	DLB	UMLS:C0752347	Lewy Body Disease
T253	Phenotype	9642	9656	hallucinations	HPO:HP:0000738	Hallucinations
T254	Phenotype	9706	9741	misperceptions of ambiguous stimuli	null	null
T26	Disease	9897	9900	DLB	UMLS:C0752347	Lewy Body Disease
T256	Phenotype	9859	9870	pareidolias	null	null
T217	Disease	9906	9925	Alzheimer’s disease	UMLS:C0002395	Alzheimer's Disease
T198	Drug	9995	10027	cholinesterase inhibitor therapy	UMLS:C0008425	Cholinesterase Inhibitors
T199	Drug	10148	10172	cholinesterase inhibitor	UMLS:C0008425	Cholinesterase Inhibitors
T208	Disease	10072	10075	PDD	UMLS:C0349081	Dementia in Parkinson's disease
T258	Phenotype	10121	10142	visual hallucinations	HPO:HP:0002367	Visual hallucinations
T259	Phenotype	10187	10201	hallucinations	HPO:HP:0000738	Hallucinations
T260	Phenotype	10317	10322	falls	HPO:HP:0002527	Falls
T27	Disease	10385	10388	DLB	UMLS:C0752347	Lewy Body Disease
T261	Phenotype	10356	10381	neuropsychiatric symptoms	UMLS:C3534763	One or more neuropsychiatric symptoms
T262	Drug	10427	10454	anticholinergic medications	UMLS:C0242896	Anticholinergic Agents
T263	Drug	10456	10466	amantadine	DrugBank:DB00915	Amantadine
T264	Drug	10468	10485	dopamine agonists	UMLS:C0178601	Dopamine Agonists
T265	Drug	10487	10515	monoamine oxidase inhibitors	UMLS:C0026457	Monoamine Oxidase Inhibitors
T266	Drug	10517	10557	catechol-O-methyl transferase inhibitors	UMLS:C0595267	Catechol-O-methyltransferase inhibitor
T267	Drug	10563	10571	levodopa	DrugBank:DB01235	Levodopa
T268	Disease	10627	10657	neuroleptic malignant syndrome	UMLS:C0027849	Neuroleptic Malignant Syndrome
T28	Disease	10711	10714	DLB	UMLS:C0752347	Lewy Body Disease
T269	Drug	10737	10762	antipsychotic medications	UMLS:C0040615	Antipsychotic Agents
T56	Disease	10801	10809	dementia	UMLS:C0497327	Dementia
T270	Disease	10767	10786	Alzheimer’s disease	UMLS:C0002395	Alzheimer's Disease
T271	Drug	10819	10844	antipsychotic medications	UMLS:C0040615	Antipsychotic Agents
T235	Phenotype	10922	10928	stroke	HPO:HP:0001297	Stroke
T57	Disease	11200	11218	end-stage dementia	UMLS:C0497327	Dementia
T273	Drug	11282	11296	antipsychotics	UMLS:C0040615	Antipsychotic Agents
T58	Disease	11425	11433	dementia	UMLS:C0497327	Dementia
T274	Drug	11393	11417	antipsychotic medication	UMLS:C0040615	Antipsychotic Agents
T29	Disease	11579	11582	DLB	UMLS:C0752347	Lewy Body Disease
T59	Disease	11593	11601	dementia	UMLS:C0497327	Dementia
T275	Drug	11550	11575	antipsychotic medications	UMLS:C0040615	Antipsychotic Agents
T276	Phenotype	11634	11648	Hallucinations	HPO:HP:0000738	Hallucinations
T277	Phenotype	11653	11662	delusions	HPO:HP:0000746	Delusions
T278	Phenotype	11716	11738	behavioral disturbance	HPO:HP:0000708	Behavioral abnormality
T279	Drug	11797	11809	neuroleptics	UMLS:C0040615	Antipsychotic Agents
T280	Drug	12130	12153	antipsychotic treatment	UMLS:C0040615	Antipsychotic Agents
T281	Phenotype	12232	12241	psychosis	HPO:HP:0000709	Psychosis
T282	Measure	12269	12295	Neuropsychiatric Inventory	UMLS:C3539727	Neuropsychiatric Inventory Questionnaire
T283	Drug	12447	12469	neuroleptic medication	UMLS:C0040615	Antipsychotic Agents
T30	Disease	12499	12502	DLB	UMLS:C0752347	Lewy Body Disease
T284	Drug	12540	12564	antipsychotic medication	UMLS:C0040615	Antipsychotic Agents
T286	Drug	12597	12608	neuroleptic	UMLS:C0040615	Antipsychotic Agents
T254	Drug	12660	12682	Typical antipsychotics	UMLS:C2917392	Typical Antipsychotic [EPC]
T288	Drug	12697	12708	haloperidol	DrugBank:DB00502	Haloperidol
T289	Drug	12767	12778	neuroleptic	UMLS:C0040615	Antipsychotic Agents
T291	Phenotype	12915	12924	confusion	HPO:HP:0001289	Confusion
T292	Phenotype	12926	12955	exacerbations of parkinsonism	HPO:HP:0001300	Parkinsonism
T293	Phenotype	12957	12965	rigidity	HPO:HP:0002063	Rigidity
T294	Phenotype	12967	12979	dysautonomia	HPO:HP:0002459	Dysautonomia
T296	Phenotype	13182	13199	cognitive decline	HPO:HP:0001268	Mental deterioration
T31	Disease	13313	13316	DLB	UMLS:C0752347	Lewy Body Disease
T297	Drug	13259	13284	Antipsychotic medications	UMLS:C0040615	Antipsychotic Agents
T298	Phenotype	13410	13419	psychosis	HPO:HP:0000709	Psychosis
T299	Disease	13468	13487	Alzheimer’s disease	UMLS:C0002395	Alzheimer's Disease
T300	Drug	13605	13619	antipsychotics	UMLS:C0040615	Antipsychotic Agents
T301	Drug	13698	13722	antipsychotics treatment	UMLS:C0040615	Antipsychotic Agents
T302	Drug	13766	13780	antipsychotics	UMLS:C0040615	Antipsychotic Agents
T303	Drug	13854	13867	antipsychotic	UMLS:C0040615	Antipsychotic Agents
T32	Disease	14065	14068	DLB	UMLS:C0752347	Lewy Body Disease
T209	Disease	13964	13967	PDD	UMLS:C0349081	Dementia in Parkinson's disease
T210	Disease	14069	14072	PDD	UMLS:C0349081	Dementia in Parkinson's disease
T304	Drug	13901	13911	Quetiapine	DrugBank:DB01224	Quetiapine
T305	Drug	13916	13925	clozapine	DrugBank:DB00363	Clozapine
T306	Drug	14028	14038	quetiapine	DrugBank:DB01224	Quetiapine
T307	Drug	14165	14175	quetiapine	DrugBank:DB01224	Quetiapine
T308	Drug	14187	14196	clozapine	DrugBank:DB00363	Clozapine
T309	Phenotype	14271	14286	agranulocytosis	HPO:HP:0012234	Agranulocytosis
T33	Disease	14369	14372	DLB	UMLS:C0752347	Lewy Body Disease
T310	Drug	14334	14358	antipsychotic medication	UMLS:C0040615	Antipsychotic Agents
T311	Drug	14417	14442	antipsychotic medications	UMLS:C0040615	Antipsychotic Agents
T312	Disease	14508	14516	diabetes	UMLS:C0011847	Diabetes
T313	Disease	14520	14534	hyperlipidemia	UMLS:C0020473	Hyperlipidemia
T314	Drug	14548	14558	quetiapine	DrugBank:DB01224	Quetiapine
T315	Drug	14560	14570	olanzapine	DrugBank:DB00334	Olanzapine
T316	Drug	14575	14584	clozapine	DrugBank:DB00363	Clozapine
T317	Drug	14648	14658	olanzapine	DrugBank:DB00334	Olanzapine
T318	Drug	14663	14674	risperidone	DrugBank:DB00734	Risperidone
T82	Disease	14733	14735	PD	UMLS:C0030567	Parkinson Disease
T319	Drug	14681	14691	Olanzapine	DrugBank:DB00334	Olanzapine
T321	Phenotype	14750	14759	psychosis	HPO:HP:0000709	Psychosis
T34	Disease	14884	14887	DLB	UMLS:C0752347	Lewy Body Disease
T83	Disease	14831	14833	PD	UMLS:C0030567	Parkinson Disease
T322	Drug	14813	14823	olanzapine	DrugBank:DB00334	Olanzapine
T212	Disease	15020	15037	synucleinopathies	null	null
T323	Drug	14920	14944	antipsychotic medication	UMLS:C0040615	Antipsychotic Agents
T200	Drug	15121	15145	cholinesterase inhibitor	UMLS:C0008425	Cholinesterase Inhibitors
T201	Drug	15150	15173	neuroleptic medications	UMLS:C0040615	Antipsychotic Agents
T203	Drug	15305	15317	pimavanserin	DrugBank:DB05316	Pimavanserin
T211	Disease	15405	15408	PDD	UMLS:C0349081	Dementia in Parkinson's disease
T324	Phenotype	15469	15478	Agitation	HPO:HP:0000713	Agitation
T325	Phenotype	15483	15505	behavioral disturbance	HPO:HP:0000708	Behavioral abnormality
T326	Phenotype	15650	15659	agitation	HPO:HP:0000713	Agitation
T327	Phenotype	15690	15699	agitation	HPO:HP:0000713	Agitation
T328	Drug	15664	15672	fleeting	UMLS:C0591516	Fleet
T329	Drug	15762	15775	antipsychotic	UMLS:C0040615	Antipsychotic Agents
T330	Phenotype	15880	15884	pain	HPO:HP:0012531	Pain
T331	Phenotype	15845	15878	difficulty expressing their needs	null	null
T332	Phenotype	15908	15917	agitation	HPO:HP:0000713	Agitation
T333	Phenotype	15958	15962	pain	HPO:HP:0012531	Pain
T334	Drug	15997	16007	analgesics	UMLS:C0002771	Analgesics
T335	Drug	16016	16029	acetaminophen	DrugBank:DB00316	Acetaminophen
T336	Drug	16065	16090	Antipsychotic medications	UMLS:C0040615	Antipsychotic Agents
T337	Phenotype	16162	16185	behavioral disturbances	HPO:HP:0000708	Behavioral abnormality
T338	Phenotype	16194	16222	sleep–wake cycle disturbance	HPO:HP:0006979	Sleep-wake cycle disturbance
T339	Phenotype	16224	16232	shouting	UMLS:C0562551	Shouting
T340	Phenotype	16234	16255	oppositional behavior	UMLS:C2013199	oppositional behavior
T309	Phenotype	16257	16263	pacing	UMLS:C0562458	Pacing up and down
T342	Phenotype	16265	16274	agitation	HPO:HP:0000713	Agitation
T343	Phenotype	16280	16290	aggression	HPO:HP:0000718	Aggressive behavior
T344	Drug	16331	16354	neuroleptic medications	UMLS:C0040615	Antipsychotic Agents
T60	Disease	16641	16668	moderate to severe dementia	UMLS:C3494871	Moderate dementia
T90	Disease	16641	16668	moderate to severe dementia	UMLS:C3494652	Severe dementia
T35	Disease	16865	16868	DLB	UMLS:C0752347	Lewy Body Disease
T84	Disease	16899	16901	PD	UMLS:C0030567	Parkinson Disease
T85	Phenotype	16913	16921	rigidity	HPO:HP:0002063	Rigidity
T86	Phenotype	16923	16935	bradykinesia	HPO:HP:0002067	Bradykinesia
T87	Phenotype	16937	16943	tremor	HPO:HP:0001337	Tremor
T88	Phenotype	16949	16966	gait difficulties	HPO:HP:0001288	Gait disturbance
T89	Phenotype	16837	16851	motor symptoms	UMLS:C0426980	Motor symptoms
T345	Treatment	16988	17004	physical therapy	UMLS:C0949766	Physical therapy
T36	Disease	17105	17108	DLB	UMLS:C0752347	Lewy Body Disease
T91	Disease	17053	17055	PD	UMLS:C0030567	Parkinson Disease
T346	Phenotype	17083	17088	falls	HPO:HP:0002527	Falls
T347	Phenotype	17222	17236	Repeated falls	HPO:HP:0002359	Frequent falls
T37	Disease	17377	17380	DLB	UMLS:C0752347	Lewy Body Disease
T92	Disease	17340	17342	PD	UMLS:C0030567	Parkinson Disease
T93	Disease	17426	17428	PD	UMLS:C0030567	Parkinson Disease
T38	Disease	17535	17538	DLB	UMLS:C0752347	Lewy Body Disease
T350	Drug	17548	17566	Levodopa/carbidopa	UMLS:C0353697	Carbidopa / Levodopa
T351	Phenotype	17609	17621	parkinsonism	HPO:HP:0001300	Parkinsonism
T353	Drug	17668	17686	Levodopa/carbidopa	UMLS:C0353697	Carbidopa / Levodopa
T354	Drug	17716	17733	dopamine agonists	UMLS:C0178601	Dopamine Agonists
T94	Disease	17823	17825	PD	UMLS:C0030567	Parkinson Disease
T356	Drug	17842	17859	dopamine agonists	UMLS:C0178601	Dopamine Agonists
T357	Drug	17939	17949	Amantadine	DrugBank:DB00915	Amantadine
T359	Phenotype	18023	18035	dysautonomia	HPO:HP:0002459	Dysautonomia
T360	Phenotype	18040	18054	hallucinations	HPO:HP:0000738	Hallucinations
T95	Disease	18117	18119	PD	UMLS:C0030567	Parkinson Disease
T204	Drug	18121	18146	Cholinesterase inhibitors	UMLS:C0008425	Cholinesterase Inhibitors
T362	Phenotype	18162	18168	tremor	HPO:HP:0001337	Tremor
T363	Phenotype	18218	18230	parkinsonism	HPO:HP:0001300	Parkinsonism
T364	Phenotype	18285	18297	parkinsonism	HPO:HP:0001300	Parkinsonism
T365	Drug	18336	18375	dopamine receptor blocking anti-emetics	null	null
T366	Drug	18390	18406	prochlorperazine	DrugBank:DB00433	Prochlorperazine
T367	Drug	18411	18425	metoclopramide	DrugBank:DB01233	Metoclopramide
T368	Drug	18431	18443	neuroleptics	UMLS:C0040615	Antipsychotic Agents
T96	Disease	18534	18536	PD	UMLS:C0030567	Parkinson Disease
T216	Disease	18488	18503	synucleinopathy	null	null
T369	Phenotype	18551	18563	constipation	HPO:HP:0002019	Constipation
T370	Phenotype	18567	18575	diarrhea	HPO:HP:0002014	Diarrhea
T347	Phenotype	18636	18653	bowel obstruction	null	null
T39	Disease	18724	18727	DLB	UMLS:C0752347	Lewy Body Disease
T372	Drug	18895	18910	stool softeners	UMLS:C0301470	Stool Softener
T373	Treatment	18912	18920	psyllium	UMLS:C0033979	Psyllium
T374	Drug	18927	18946	polyethylene glycol	DrugBank:DB09287	Polyethylene glycol
T375	Drug	18953	18968	methylcellulose	UMLS:C0025729	Methylcellulose
T376	Drug	18970	18978	docusate	UMLS:C1692318	Docusate
T377	Drug	18984	18995	misoprostol	DrugBank:DB00929	Misoprostol
T205	Drug	19095	19127	cholinesterase inhibitor therapy	UMLS:C0008425	Cholinesterase Inhibitors
T357	Phenotype	19016	19040	Increased bowel activity	null	null
T97	Disease	19143	19145	PD	UMLS:C0030567	Parkinson Disease
T379	Phenotype	19166	19210	urinary frequency, urgency, and incontinence	UMLS:C0042023	Increased frequency of micturition
T380	Phenotype	19166	19210	urinary frequency, urgency, and incontinence	HPO:HP:0000012	Urinary urgency
T381	Phenotype	19166	19210	urinary frequency, urgency, and incontinence	HPO:HP:0000020	Urinary incontinence
T382	Drug	19232	19240	trospium	DrugBank:DB00209	Trospium
T383	Drug	19257	19268	oxybutyinin	DrugBank:DB01062	Oxybutynin
T384	Drug	19304	19319	trihexyphenidyl	DrugBank:DB00376	Trihexyphenidyl
T385	Drug	19329	19340	oxybutyinin	DrugBank:DB01062	Oxybutynin
T386	Phenotype	19354	19363	confusion	HPO:HP:0001289	Confusion
T387	Drug	19376	19386	Tamsulosin	DrugBank:DB00706	Tamsulosin
T389	Phenotype	19427	19437	prostatism	UMLS:C0242453	Prostatism
T390	Phenotype	19442	19459	urinary retention	HPO:HP:0000016	Urinary retention
T98	Disease	19518	19520	PD	UMLS:C0030567	Parkinson Disease
T391	Drug	19466	19476	Sildenafil	DrugBank:DB00203	Sildenafil
T392	Phenotype	19494	19514	erectile dysfunction	HPO:HP:0000802	Impotence
T393	Drug	19598	19606	levodopa	DrugBank:DB01235	Levodopa
T394	Drug	19610	19636	dopamine agonist treatment	UMLS:C0178601	Dopamine Agonists
T395	Phenotype	19649	19669	hypersexual behavior	HPO:HP:0030214	Hypersexuality
T40	Disease	19715	19718	DLB	UMLS:C0752347	Lewy Body Disease
T396	Phenotype	19680	19700	Orthostatic symptoms	null	null
T215	Phenotype	19833	19850	postural symptoms	null	null
T397	Phenotype	19884	19892	weakness	UMLS:C3714552	Weakness
T398	Phenotype	19896	19904	lethargy	HPO:HP:0001254	Lethargy
T214	Disease	20117	20134	synucleinopathies	null	null
T399	Drug	19932	19959	antihypertensive medication	UMLS:C0003364	Antihypertensive Agents
T400	Drug	20049	20064	fludrocortisone	DrugBank:DB00687	Fludrocortisone
T401	Drug	20075	20086	domperidone	DrugBank:DB01184	Domperidone
T402	Drug	20171	20185	pyrodostigmine	DrugBank:DB00545	Pyridostigmine
T403	Phenotype	20264	20284	excessive sleepiness	UMLS:C0917799	Hypersomnia
T404	Drug	20326	20346	Sedating medications	UMLS:C0036557	Sedatives
T388	Phenotype	20368	20391	obstructive sleep apnea	HPO:HP:0002870	Obstructive sleep apnea
T406	Disease	20393	20416	primary sleep disorders	UMLS:C0236991	primary sleep disorders
T390	Phenotype	20422	20430	nocturia	HPO:HP:0000017	Nocturia
T408	Drug	20452	20460	Caffeine	DrugBank:DB00201	Caffeine
T410	Disease	20543	20564	restless leg syndrome	UMLS:C0035258	Restless Legs Syndrome
T411	Drug	20588	20603	methylphenidate	DrugBank:DB00422	Methylphenidate
T412	Drug	20608	20625	dextroamphetamine	DrugBank:DB01576	Dextroamphetamine
T99	Disease	20681	20683	PD	UMLS:C0030567	Parkinson Disease
T413	Drug	20641	20650	Modafinil	DrugBank:DB00745	Modafinil
T414	Drug	20771	20782	armodafinil	UMLS:C1701455	armodafinil
T41	Disease	20812	20815	DLB	UMLS:C0752347	Lewy Body Disease
T418	Phenotype	20825	20845	act out their dreams	null	null
T399	Disease	20887	20929	rapid eye movement sleep behavior disorder	UMLS:C0751772	REM Sleep Behavior Disorder
T416	Disease	20954	20976	disorders of synuclein	null	null
T417	Phenotype	21040	21068	excessive daytime sleepiness	HPO:HP:0002189	Excessive daytime sleepiness
T419	Phenotype	21312	21325	enacted dream	null	null
T420	Drug	21514	21523	melatonin	DrugBank:DB01065	Melatonin
T421	Drug	21535	21547	rivastigmine	DrugBank:DB00989	Rivastigmine
T406	Disease	21634	21676	rapid eye movement sleep behavior disorder	UMLS:C0751772	REM Sleep Behavior Disorder
T423	Drug	21712	21721	melatonin	DrugBank:DB01065	Melatonin
T424	Drug	21795	21805	clonazepam	DrugBank:DB01068	Clonazepam
T425	Disease	21887	21909	disorders of synuclein	null	null
T426	Disease	22001	22032	periodic limb movement disorder	UMLS:C0751774	Nocturnal Myoclonus Syndrome
T42	Disease	22221	22224	DLB	UMLS:C0752347	Lewy Body Disease
T427	Disease	22136	22157	restless leg syndrome	UMLS:C0035258	Restless Legs Syndrome
T428	Disease	22161	22192	periodic limb movement disorder	UMLS:C0751774	Nocturnal Myoclonus Syndrome
T429	Drug	22230	22247	dopamine agonists	UMLS:C0178601	Dopamine Agonists
T100	Disease	22573	22575	PD	UMLS:C0030567	Parkinson Disease
T430	Disease	22340	22361	restless leg syndrome	UMLS:C0035258	Restless Legs Syndrome
T431	Disease	22366	22388	limb movement disorder	UMLS:C0751774	Nocturnal Myoclonus Syndrome
T432	Drug	22394	22412	carbidopa/levodopa	UMLS:C0353697	Carbidopa / Levodopa
T433	Drug	22414	22429	benzodiazepines	UMLS:C0005064	Benzodiazepines
T434	Drug	22446	22456	clonazepam	DrugBank:DB01068	Clonazepam
T435	Drug	22467	22504	alpha-2-delta calcium channel ligands	null	null
T436	Drug	22506	22516	gabapentin	DrugBank:DB00996	Gabapentin
T437	Drug	22518	22538	gabapentin enacarbil	DrugBank:DB08872	gabapentin enacarbil
T438	Drug	22544	22554	pregabalin	DrugBank:DB00230	Pregabalin
T43	Disease	22592	22595	DLB	UMLS:C0752347	Lewy Body Disease
T65	Phenotype	22787	22808	visual hallucinations	HPO:HP:0002367	Visual hallucinations
T66	Phenotype	22814	22826	parkinsonism	HPO:HP:0001300	Parkinsonism
T67	Phenotype	22905	22917	parkinsonism	HPO:HP:0001300	Parkinsonism
T68	Treatment	23091	23109	nondrug treatments	null	null
T69	Drug	23190	23219	anti-hypertensive medications	UMLS:C0003364	Antihypertensive Agents
T70	Phenotype	23266	23284	postural dizziness	UMLS:C0234987	Postural dizziness
T71	Disease	23293	23314	alpha-synucleinopathy	null	null
T44	Disease	23582	23585	DLB	UMLS:C0752347	Lewy Body Disease
T72	Drug	23393	23418	antipsychotic medications	UMLS:C0040615	Antipsychotic Agents
T73	Phenotype	23461	23475	hallucinations	HPO:HP:0000738	Hallucinations
T74	Phenotype	23480	23489	delusions	HPO:HP:0000746	Delusions
T75	Phenotype	23520	23538	prolonged rigidity	HPO:HP:0002063	Rigidity
T76	Phenotype	23543	23567	decreased responsiveness	UMLS:C3276433	Decreased mental alertness
T62	Drug	23604	23618	antipsychotics	UMLS:C0040615	Antipsychotic Agents
